Back

Diabetes and heart failure after acute myocardial infarction. The FAST-MI programme

3 September 2019 (14:48 - 15:06)
Organised by:
Congress Presentation Part of: Late Breaking Science in Heart Failure 2 Epidemiology, Prognosis, Outcome ESC Premium Access ESC Congress 2019

About the speaker

Photo
Professor Nicolas Danchin

Saint Joseph Hospital, Paris (France)

4 More presentations in this session

Presentation thumbnail
Dynamic changes in cardiac structures: novel aspects of the pathophysiology of heart failure with preserved left ventricular ejection fraction -a report from the CHART-2 Study-
Professor H. Shimokawa (Sendai, JP)
Slides Video
Presentation thumbnail
Natriuretic Peptide Metabolisation is Associated with Clinical Outcome in Chronic Heart Failure: a Step Towards Personalized Heart Failure Guidance
Doctor R. van Kimmenade (Heerlen, NL)
Slides Video
Presentation thumbnail
Current characteristics and treatment of patients with heart failure with reduced ejection fraction in outpatients in Europe.Baseline results of ARIADNE
Doctor A. Maggioni (Florence, IT)
Slides Video
Presentation thumbnail
Association between beta-blocker use and mortality/morbidity in elderly patients with heart failure with reduced ejection fraction: a prospective propensity score-matched cohort study
Professor G. Savarese (Stockholm, SE)
Slides Video

Access the full session

Session thumbnail
Late Breaking Science in Heart Failure 2

The Event

Event poster

ESC Congress 2019

3 September 2019 14:48 CET
You may be interested in
thumbnail
Congress Presentation
Myocardial infarction, diabetes and heart failure: a deadly combination
29 June 2021
thumbnail
Congress Session
Bridging gaps in heart failure care: primary care trends, exercise, kidney function, and global health perspectives
19 May 2025
thumbnail
Congress Session
French symposium: future directions in the treatment of acute coronary syndromes
26 March 2023
thumbnail
Congress Presentation
A phase 2a trial investigating ninerafaxstat - a novel cardiac mitotrope for the treatment of diabetic cardiomyopathy (IMPROVE-DiCE)
26 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources